Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (Mds)
Agios宣佈FDA授予Tebapivat(AG-946)孤兒藥物認定,用於治療骨髓增生異常綜合徵(MDS)
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (Mds)
Agios宣佈FDA授予Tebapivat(AG-946)孤兒藥物認定,用於治療骨髓增生異常綜合徵(MDS)
譯文內容由第三人軟體翻譯。